Droxinavir

Droxinavir
Names
	IUPAC name 3-tert-butyl-1-[(2R,3S)-3-[(2S)-3,3-dimethyl-2-[2-(methylamino)acetamido]butyramido]-2-hydroxy-4-phenylbutyl-1-isopentylurea
	Other names SC 55389A
Identifiers
CAS Number	159910-86-8 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL2110878 ;
ChemSpider	409165 ;
PubChem CID	70683043;
UNII	3CF21QCB9J ;
CompTox Dashboard (EPA)	DTXSID30166769 ;
	InChI InChI=1S/C29H51N5O4/c1-19(2)15-22(26(37)34-29(6,7)8)31-17-23(35)21(16-20-13-11-10-12-14-20)32-27(38)25(28(3,4)5)33-24(36)18-30-9/h10-14,19,21-23,25,30-31,35H,15-18H2,1-9H3,(H,32,38)(H,33,36)(H,34,37)/t21-,22?,23+,25+/m0/s1 Key: PLQLXAKSONXQOQ-XCZUPJPTSA-N ;
	SMILES CC(C)CC(C(=O)NC(C)(C)C)NCC(C(CC1=CC=CC=C1)NC(=O)C(C(C)(C)C)NC(=O)CNC)O;
Properties
Chemical formula	C29H51N5O4
Molar mass	533.75 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). (what is ?) Infobox references

Droxinavir (also known as SC 55389A) was an experimental protease inhibitor researched by Pharmacia as a treatment for HIV infection. Its research and development was discontinued on March 06, 1995.^[1]

References

^ "Drug Profile: Droxinavir". AdisInsight. Adis International Ltd, part of Springer Science+Business Media. Retrieved 23 November 2015.

[1] "Drug Profile: Droxinavir". AdisInsight. Adis International Ltd, part of Springer Science+Business Media. Retrieved 23 November 2015.

[1]